Arguments For New Chantix MDL To Be Heard Dec. 1 By Judicial Panel
WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) will hear arguments Dec. 1 on whether to centralize eight federal lawsuits alleging that the smoking cessation drug Chantix was contaminated...To view the full article, register now.
Already a subscriber? Click here to view full article